Mauro Gitto on Comparison of Paclitaxel-coated Balloons with Urea or Iopromide
Mauro Gitto, Interventional Cardiologist at Humanitas Research Hospital, shared on LinkedIn:
”Our latest article comparing two contemporary paclitaxel-coated balloons (urea-coated Prevail vs iopromide-coated Sequent Please) for the treatment of both de novo and ISR lesions.
As evidence in support of DCB-based PCI grows, more and more device-comparing studies are needed!
Full text here.”
Read the full article here.
Article: Paclitaxel-coated balloon with urea or iopromide as the excipient for treatment of coronary artery disease
Authors: Mauro Gitto, Francesco Tartaglia, Pier Pasquale Leone, Gianmaria Calamita, Alessandro Gabrielli, Leon Gramss, Marco Luciano Rossi, Damiano Regazzoli, Gabriele Gasparini, Ottavia Cozzi, Bernhard Reimers, Giulio Giuseppe Stefanini, Antonio Mangieri, Azeem Latib, Antonio Colombo
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 23, 2026, 22:49Giovanni Merlino: Why Does Stress Hyperglycemia Worsen Stroke Outcomes?
-
Jun 23, 2026, 22:41Tareq Abadl: Coombs Test – The Key to Detecting Immune-Mediated Hemolysis
-
Jun 23, 2026, 22:32How WFH Impacted the Bleeding Disorders Community in 2025
-
Jun 23, 2026, 18:27Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Jun 23, 2026, 18:17What Every ITP Patient Wants to Know – ITP Support Association
-
Jun 23, 2026, 18:13Ahsan Fareed: Exploring Heart Failure Readmissions in Iron Deficiency Anemia
-
Jun 23, 2026, 18:09Swarnava Roy: Key Findings on Stress Erythropoiesis and Mitochondrial Retention in RBCs
-
Jun 23, 2026, 17:40Hossam El Benawi: How do We Predict Recurrence Post LVT Resoultion?
-
Jun 23, 2026, 17:39Nicolas Gendron: Do We Really Need All These Hemostasis Tests in Patients on DOACs?